Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Ruisen Pharmaceutical Co., Ltd. is a Chinese pharmaceutical manufacturing company based in Handan, Hebei Province. Established in its current form in 2019, the company's origins trace back to the early 1990s as Hebei Donglong Pharmaceutical. The company specializes in the production of chemical pharmaceuticals, with a portfolio encompassing over 30 varieties of western medicine tablets, hard capsules, and active pharmaceutical ingredients (APIs). Key commercial products include metronidazole tablets, aspirin enteric-coated tablets, oryzanol tablets, vitamin C tablets, and troxerutin tablets, alongside specialized APIs like Mortierella alpina powder. Recognized as a high-tech and specialized small and medium-sized enterprise, Hebei Ruisen Pharmaceutical focuses on providing high-quality generic medications and essential healthcare products to the domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 河北瑞森药业.